FDA authorizes Pfizer for ages 12 through 15

Staff Report

Adolescents ages 12 through 15 could soon receive the Pfizer-BioNTech COVID-19 vaccine.

On Monday, the U.S. Food and Drug Administration (FDA) authorized the vaccine for emergency use to include a younger age range. Teens at least 16 years old and all adults were already eligible.

“[The decision] is a significant step in the fight against the COVID-19 pandemic,” said Janet Woodcock, FDA Commissioner. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.”

Woodcock added that the FDA critically reviewed available data before issuing COVID-19 vaccine emergency use authorizations (EUA).

The Centers for Disease Control and Prevention’s (CDC) vaccine advisory committee will meet Wednesday, May 12, to review whether to distribute the doses to adolescents.

For more information, please visit  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use

Comment on this Article

About Author

Megan Navarro (Wehring) graduated from Texas State University in May 2020 with a bachelor's degree in journalism and mass communication. In June 2020, she started a summer internship at the Hays Free Press/News-Dispatch through the Dow Jones News Fund and Texas Press Association. She then earned her way to a reporter position later that summer and now, she serves as the editor of the newspaper. Working for a small publication, Navarro wears multiple hats. She has various responsibilities including managing a team of reporters, making editorial decisions, overseeing social media posts, fact checking, writing her own articles and more. Navarro has a heart for storytelling and she believes that journalists are equipped to share the stories that are important to the community.

Comments are closed.